Federated Hermes’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-807,281
Closed -$26M 2252
2019
Q1
$26M Sell
807,281
-76,819
-9% -$2.38M 0.06% 288
2018
Q4
$24.9M Hold
884,100
0.07% 285
2018
Q3
$25.4M Sell
884,100
-100
-0% -$3K 0.06% 301
2018
Q2
$33.1M Buy
884,200
+600
+0.1% +$23.6K 0.1% 177
2018
Q1
$34.7M Sell
883,600
-325,197
-27% -$11.9M 0.1% 170
2017
Q4
$39.2M Buy
1,208,797
+645
+0.1% +$19.3K 0.11% 156
2017
Q3
$37.6M Sell
1,208,152
-99
-0% -$2.93K 0.11% 160
2017
Q2
$33.8M Sell
1,208,251
-106,592
-8% -$2.41M 0.1% 178
2017
Q1
$22.6M Hold
1,314,843
0.06% 261
2016
Q4
$15.9M Sell
1,314,843
-511,960
-28% -$6.63M 0.05% 306
2016
Q3
$28.9M Sell
1,826,803
-486,836
-21% -$7.33M 0.08% 191
2016
Q2
$29.9M Sell
2,313,639
-98,264
-4% -$1.54M 0.09% 179
2016
Q1
$45.8M Buy
2,411,903
+922,800
+62% +$16.7M 0.14% 127
2015
Q4
$33.5M Buy
1,489,103
+636,988
+75% +$12.6M 0.11% 184
2015
Q3
$19.9M Buy
852,115
+1,920
+0.2% +$53K 0.06% 286
2015
Q2
$24.3M Buy
850,195
+582,095
+217% +$15.3M 0.07% 281
2015
Q1
$6.92M Hold
268,100
0.02% 528
2014
Q4
$4.97M Sell
268,100
-6,900
-3% -$124K 0.02% 609
2014
Q3
$4.26M Buy
+275,000
New +$4.14M 0.01% 689

Other funds holding XENT

Federated Hermes's XENT Position: Q2 2019 in Review

Federated Hermes sold out of Intersect ENT, Inc (XENT) in Q2 2019, closing a stake of 807,281 shares — an estimated $26M sold.

Federated Hermes first reported a position in XENT in Q3 2014 and held it in 19 quarters. The position peaked at $45.8M in Q1 2016. 112 funds tracked by Wall St. Rank hold XENT as of Q2 2019.

  • Federated Hermes reported no remaining Intersect ENT, Inc position as of Q2 2019 after selling out during the quarter.
  • Federated Hermes sold 807,281 Intersect ENT, Inc shares in Q2 2019, an estimated $26M.
  • Federated Hermes first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 19 quarters.
  • Federated Hermes's Intersect ENT, Inc position peaked at $45.8M in Q1 2016.
  • 112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2019.

Based on Federated Hermes's 13F filing for Q2 2019, filed 14 Aug 2019.